| Immunotherapy studied in …STUDIED_INderived94 of 94show fewer |
|---|
| → studied in | NCT04638751suspended ARGONAUT: Stool and Blood Sample Bank for Cancer Patients · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma,Pancreatic Carcinoma,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05863052active not recruiting Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population · 94 trials list this drug (54 active) | — | — | Solid Neoplasm,Malignant Digestive System Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000253Phase 2 · recruiting Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma · 94 trials list this drug (54 active) | — | — | Malignant Esophageal Neoplasm,Childhood Gastric Carcinoma,Esophageal Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062055Phase 2 · recruiting BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases · 94 trials list this drug (54 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691645Phase 2 · not yet recruiting Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome · 94 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04151940NA · recruiting PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06410300recruiting Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy · 94 trials list this drug (54 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06627595recruiting Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management · 94 trials list this drug (54 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06974110Phase 1 · recruiting Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors · 94 trials list this drug (54 active) | — | — | Solid Neoplasm,Malignant Gastric Neoplasm,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06130826Phase 1 · recruiting Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer · 94 trials list this drug (54 active) | — | — | Breast Carcinoma,Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07596290Phase 2/Phase 3 · not yet recruiting Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC · 94 trials list this drug (54 active) | — | — | Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05328024recruiting Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma · 94 trials list this drug (54 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07162506Phase 2 · recruiting DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI · 94 trials list this drug (54 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602140Phase 2 · not yet recruiting TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study. · 94 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07258147Phase 2 · not yet recruiting Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases · 94 trials list this drug (54 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06356584Phase 2 · recruiting Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases · 94 trials list this drug (54 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06624644Phase 2/Phase 3 · recruiting A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma · 94 trials list this drug (54 active) | — | — | Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06960889active not recruiting A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients · 94 trials list this drug (54 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522411Phase 1/Phase 2 · not yet recruiting Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma · 94 trials list this drug (54 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06719700Phase 2 · recruiting Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07407166NA · recruiting Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers · 94 trials list this drug (54 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943235Phase 2 · recruiting Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC) · 94 trials list this drug (54 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05488626NA · withdrawn Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05223647Phase 3 · terminated Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06810609Phase 2 · recruiting Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978193Phase 2 · recruiting Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma · 94 trials list this drug (54 active) | — | — | Malignant Esophageal Neoplasm,Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04821778Phase 3 · recruiting Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer · 94 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04821843Phase 3 · recruiting Neoadjuvant Treatment Modalities in Esophageal Cancer · 94 trials list this drug (54 active) | — | — | Esophageal Neoplasm,Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06163053completed A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home · 94 trials list this drug (54 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06676449Phase 3 · recruiting TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC · 94 trials list this drug (54 active) | — | — | Esophageal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259473Phase 2 · not yet recruiting Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma · 94 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717166Phase 3 · recruiting A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. · 94 trials list this drug (54 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06120374recruiting Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC · 94 trials list this drug (54 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297030Phase 2 · not yet recruiting SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer · 94 trials list this drug (54 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06102057Phase 2 · recruiting PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06866951Phase 2/Phase 3 · withdrawn A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial · 94 trials list this drug (54 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07254858Phase 2 · not yet recruiting Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer · 94 trials list this drug (54 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07231575Phase 2 · not yet recruiting Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03176173NA · completed Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL) · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03721341Phase 3 · active not recruiting Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors · 94 trials list this drug (54 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06831136Phase 2 · recruiting Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma · 94 trials list this drug (54 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118566Phase 2 · not yet recruiting Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases · 94 trials list this drug (54 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07111104completed Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07098104completed A Benefit Population Atlas of nICT Versus nCT for LAGC · 94 trials list this drug (54 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07035860not yet recruiting Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07034326Phase 2/Phase 3 · recruiting Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06478355NA · unknown Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR） · 94 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218901recruiting Association of Psychological Distress in Patients With Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06966583Phase 1 · not yet recruiting NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC · 94 trials list this drug (54 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06907602Phase 2/Phase 3 · recruiting Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma · 94 trials list this drug (54 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06878222Phase 2 · recruiting Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC · 94 trials list this drug (54 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04612309active not recruiting Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer · 94 trials list this drug (54 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06798246not yet recruiting HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study · 94 trials list this drug (54 active) | — | — | Renal Pelvis and Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788366recruiting AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04724928Phase 2 · recruiting Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer · 94 trials list this drug (54 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06718309Phase 2 · recruiting Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902260NA · completed The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06599827Phase 2 · not yet recruiting Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC · 94 trials list this drug (54 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03370861terminated How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes · 94 trials list this drug (54 active) | — | — | Malignant Skin Neoplasm,Melanoma,Basal Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05229614Phase 2 · unknown Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease · 94 trials list this drug (54 active) | — | — | Melanoma,Head and Neck Squamous Cell Carcinoma,Lung Non-Small Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06518018unknown Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084676terminated Organoid Model Predictive of Response to Immunotherapies · 94 trials list this drug (54 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02949843Phase 2 · terminated Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06292052completed Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness · 94 trials list this drug (54 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06326086unknown Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment. · 94 trials list this drug (54 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636592active not recruiting Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06287320unknown The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06249750Phase 2 · recruiting Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer · 94 trials list this drug (54 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242329Phase 2 · withdrawn Surgery of Melanoma Metastases After Systemic Therapy · 94 trials list this drug (54 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205823unknown Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM · 94 trials list this drug (54 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06202885unknown CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy · 94 trials list this drug (54 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04558684Phase 1/Phase 2 · suspended Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer · 94 trials list this drug (54 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05418660unknown Observational Retro-prospective Study on PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031597Phase 3 · unknown Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05892237Phase 2 · unknown CIETAI and Sequential Radiotherapy in Squamous Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04435964completed Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment · 94 trials list this drug (54 active) | — | — | Malignant Breast Neoplasm,Malignant Head and Neck Neoplasm,Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04650490Phase 2 · withdrawn SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05111197Phase 3 · unknown Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05202314NA · recruiting Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer · 94 trials list this drug (54 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04359199unknown QUantitative Assessment of Swallowing After Radiation (QUASAR) · 94 trials list this drug (54 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Oropharyngeal Neoplasm,Oropharynx Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077280Phase 2 · unknown A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma · 94 trials list this drug (54 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05481775Phase 2 · withdrawn Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04688801NA · recruiting Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer · 94 trials list this drug (54 active) | — | — | Esophageal Neoplasm,Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05507411Phase 2 · recruiting Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC · 94 trials list this drug (54 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05486988unknown ctDNA as a Biomarker for Treatment in Advanced NSCLC · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05137912unknown Neoadjuvant Immunotherapy in Advanced NSCLC · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291092Phase 2 · unknown Camrelizumab Combined With Local Treatment in NSCLC Patients With BM · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04465942unknown Immunotherapy in Lung Cancer: Treatment After IO Cessation. · 94 trials list this drug (54 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04873440Phase 1/Phase 2 · unknown An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma · 94 trials list this drug (54 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04286841recruiting The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China · 94 trials list this drug (54 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03580070completed Changes in the Microenvironment of HPV-induced Head and Neck Cancers in West Indies and Metropolitan Population · 94 trials list this drug (54 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02539017Phase 2 · withdrawn The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer · 94 trials list this drug (54 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02783885unknown Clinical Utilization of Newly Approved Oncology Medications · 94 trials list this drug (54 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00697671Phase 1 · completed Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies · 94 trials list this drug (54 active) | — | — | Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |